Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Chi

Showing results (131-140 of 410) with videos related to

Pageof 41
Sort By:
World Journal of Urology|March 1, 2018
The impact of time to metastasis on overall survival in patients with prostate cancerSebastian Frees, Shusuke Akamatsu, Samir Bidnur, et al.
The Journal of Urology|July 21, 2016
AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone AcetateTilman Todenhöfer, Arun Azad, Craig Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trialC N Sternberg, J S de Bono, K N Chi, et al.
Journal of Cancer Survivorship : Research and Practice|January 31, 2024
Cancer survivorship programs at the Dana-Farber Cancer InstituteAnn H Partridge, Alicia Morgans, Lauren P Knelson, et al.
Nature Structural & Molecular Biology|December 27, 2016
Solution structure of discoidal high-density lipoprotein particles with a shortened apolipoprotein A-IStefan Bibow, Yevhen Polyhach, Cédric Eichmann, et al.
Journal of Medicinal Chemistry|September 25, 2008
Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interactionAnders Bach, Celestine N Chi, Thomas B Olsen, et al.
The Prostate|October 30, 2018
Clinical effectiveness of docetaxel for castration-sensitive prostate cancer in a real-world population-based analysisJean-Michel Lavoie, Kevin Zou, Daniel Khalaf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastomaSusan N Chi, Sharon L Gardner, Adam S Levy, et al.
Journal of Translational Medicine|January 15, 2016
Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trialRaya Leibowitz-Amit, Melania Pintilie, Leila Khoja, et al.
Investigational New Drugs|March 28, 2014
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancerArun A Azad, Emma K Beardsley, Sebastian J Hotte, et al.
Pageof 41

Showing results (131-140 of 410) with videos related to

Sort By:
Pageof 41
World Journal of Urology|March 1, 2018
The impact of time to metastasis on overall survival in patients with prostate cancerSebastian Frees, Shusuke Akamatsu, Samir Bidnur, et al.
The Journal of Urology|July 21, 2016
AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone AcetateTilman Todenhöfer, Arun Azad, Craig Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trialC N Sternberg, J S de Bono, K N Chi, et al.
Journal of Cancer Survivorship : Research and Practice|January 31, 2024
Cancer survivorship programs at the Dana-Farber Cancer InstituteAnn H Partridge, Alicia Morgans, Lauren P Knelson, et al.
Nature Structural & Molecular Biology|December 27, 2016
Solution structure of discoidal high-density lipoprotein particles with a shortened apolipoprotein A-IStefan Bibow, Yevhen Polyhach, Cédric Eichmann, et al.
Journal of Medicinal Chemistry|September 25, 2008
Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interactionAnders Bach, Celestine N Chi, Thomas B Olsen, et al.
The Prostate|October 30, 2018
Clinical effectiveness of docetaxel for castration-sensitive prostate cancer in a real-world population-based analysisJean-Michel Lavoie, Kevin Zou, Daniel Khalaf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastomaSusan N Chi, Sharon L Gardner, Adam S Levy, et al.
Journal of Translational Medicine|January 15, 2016
Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trialRaya Leibowitz-Amit, Melania Pintilie, Leila Khoja, et al.
Investigational New Drugs|March 28, 2014
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancerArun A Azad, Emma K Beardsley, Sebastian J Hotte, et al.
Pageof 41